Faimroul 0.25% Cream
By Faimroul
30gm Cream in a Tube

Composition
Amorolfine(0.25% w/w)

Manufacturer - Parul Health Care Private Limited
29, Rajinder Nagar, Dc Colony Karnal, Hr 132001 India

Expires on or after
October, 2025

liver
In relation to liver issues, there is no interaction that has been found or established regarding the use of Faimroul 0.25% Cream. It is important to be cautious about any potential effects on the liver. Before using Faimroul 0.25% Cream, consulting with your doctor for proper guidance is recommended to ensure your safety.

kidney
No interaction with the kidney has been found or established regarding Faimroul 0.25% Cream. Consult with your doctor for proper guidance before using Faimroul 0.25% Cream.

alcohol
Currently, there is no information available regarding any interactions between alcohol and Faimroul 0.25% Cream. It is always important to consult with a healthcare provider if you have any concerns or questions about consuming alcohol while using Faimroul 0.25% Cream.

driving
No interaction found or established with Faimroul 0.25% Cream and driving. It is safe to drive while using Faimroul 0.25% Cream.

pregnancy
Information regarding the safety of using Faimroul 0.25% Cream during pregnancy is currently not available. It is recommended to consult with your healthcare provider before using this product.

breastfeeding
When using Faimroul 0.25% Cream, caution is advised during breastfeeding. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug is no longer present in her system.
Habit Forming | No |
Chemical Class | Phenylpropane Derivative |
Therapeutic Class | DERMA |
Action Class | Antifungal Others |
₹298
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024